Goodwin Steers Biotech Holding Firm's Upsized $330M IPO
Biotechnology holding company Centessa Pharmaceuticals PLC, advised by Goodwin Procter LLP and underwriters counsel Cooley LLP, rallied in debut trading Friday after raising $330 million in an upsized initial public offering,...To view the full article, register now.
Already a subscriber? Click here to view full article